SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

72,627.56 98.49
( 0.14%)

Global Indices

Nasdaq

51,369.65 -132.86
(-0.26%)

Dow Jones

7,690.99 -13.70
(-0.18%)

Hang Seng

65,155.57 -722.05
(-1.10%)

Nikkei 225

10,628.22 -56.66
(-0.53%)

Forex

USD-INR

95.79 -0.10
(-0.10%)

EUR-INR

109.09 0.01
(0.01%)

GBP-INR

126.83 0.01
(0.01%)

JPY-INR

0.61 0.00
(0.68%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Natco Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524816

INE987B01026

477.507017

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

NATCOPHARM

16.95

15115.98

EPS(TTM)

Face Value()

Div & Yield %

49.8

0.59

Back

bal pharma ltd

Regent Enterprises standalone net profit rises 54.27% in the June 2026 quarter

Aug 13,2026

Net profit of Regent Enterprises rose 54.27% to Rs 2.53 crore in the quarter ended June 2026 as against Rs 1.64 crore during the previous quarter ended June 2025. Sales declined 42.07% to Rs 138.27 crore in the quarter ended June 2026 as against Rs 238.67 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	138.27	238.67	-42
OPM %	1.27	0.74	-
PBDT	1.76	1.77	-1
PBT	1.63	1.64	-1
NP	2.53	1.64	54

72,627.56 98.49 ( 0.14%)

51,369.65 -132.86 (-0.26%)

7,690.99 -13.70 (-0.18%)

65,155.57 -722.05 (-1.10%)

10,628.22 -56.66 (-0.53%)

95.79 -0.10 (-0.10%)

109.09 0.01 (0.01%)

126.83 0.01 (0.01%)

0.61 0.00 (0.68%)